Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon

Arthritis and Rheumatism

Volumn 46, Issue 9, 2002, Pages 2410-2420

  Merkel, Peter A ^a,c   Herlyn, Karen ^a,s   Martin, Richard W ^b   Anderson, Jennifer J ^c   Mayes, Maureen D ^d,t   Bell, Patrice ^e,u   Korn, Joseph H ^c   Simms, Robert W ^c   Csuka, Mary Ellen ^f   Medsger, Thomas A ^g   Rothfield, Naomi F ^h   Ellman, Michael H ⁱ   Collier, David H ^j   Weinstein, Arthur ^k,v   Furst, Daniel E ^m,n   Jiménez, Sergio A ^o   White, Barbara ^p,q   Seibold, James R ^r   Wigley, Fredrick M ^p,q  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e BAYER PHARMA AG   (Germany)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h UNIVERSITY OF CONNECTICUT   (United States)

ⁱ UNIVERSITY OF CHICAGO   (United States)

^j UNIVERSITY OF COLORADO   (United States)

^k NEW YORK MEDICAL COLLEGE   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m BENAROYA RESEARCH INSTITUTE   (United States)

ⁿ Thomas Jefferson University ^*

^o THOMAS JEFFERSON UNIVERSITY   (United States)

^p UNIVERSITY OF MARYLAND   (United States)

^q JOHNS HOPKINS UNIVERSITY   (United States)

^r UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^s UNIVERSITY OF LÜBECK   (Germany)

^t UNIVERSITY OF TEXAS   (United States)

^u Mental Health Outcomes   (United States)

^v WASHINGTON HOSPITAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ILOPROST;

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISABILITY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; EATING; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HAND GRIP; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; MULTICENTER STUDY; OUTCOMES RESEARCH; PAIN; PHYSICIAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RAYNAUD PHENOMENON; RELIABILITY; SCLERODERMA; SCORING SYSTEM; SKIN ULCER; VALIDATION PROCESS; VISUAL ANALOG SCALE;

AFFECT; AGED; AGED, 80 AND OVER; DISABLED PERSONS; EXTREMITIES; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; MULTICENTER STUDIES; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; RAYNAUD DISEASE; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; ULCER;

EID: 0036746069     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10486     Document Type: Article

References (25)

1. Wigley FM, Korn JH, Csuka ME, Medsger TA Jr, Rothfield NF, Ellman M, et al. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. Arthritis Rheum 1998;41:670-7.
2. Dziadzio M, Denton CP, Smith R, Howell K, Blann A, Bowers E, et al. Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial. Arthritis Rheum 1999;42:2646-55.
3. Merkel PA. Measurement of functional status, self-assessment, and psychological well-being in scleroderma. Curr Opin Rheumatol 1998;10:589-94.
4. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
5. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
6. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the Health Assessment Questionnaire, disability and pain scales. J Rheumatol 1982;9:789-93.
7. Poole JL, Steen VD. The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 1991;4:27-31.
8. Moser DK, Clements PJ, Brecht M-L, Weiner SR. Predictors of psychosocial adjustment in systemic sclerosis: the influence of formal education level, functional ability, hardiness, uncertainty, and social support. Arthritis Rheum 1993;36:1398-405.
9. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20:1892-6.
10. Poole JL, Williams CA, Bloch DA, Hollak B, Spitz P. Concurrent validity of the Health Assessment Questionnaire disability index in scleroderma. Arthritis Care Res 1995;8:189-93.
11. Malcarne VL, Greenbergs HL. Psychological adjustment to systemic sclerosis. Arthritis Care Res 1996;9:51-9.
12. Roca RP, Wigley FM, White B. Depressive symptoms associated with scleroderma. Arthritis Rheum 1996;39:1035-40.
13. Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91.
14. Meenan RF, Gertman PM, Mason JH. Measuring health status in arthritis: the Arthritis Impact Measurement Scales. Arthritis Rheum 1980;23:146-52.
15. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE. AIMS2: the content and properties of a revised and expanded Arthritis Impact Measurement Scales health status questionnaire. Arthritis Rheum 1992;35:1-10.
16. Kim J, Mueller C. Factor analysis: statistical methods and practical issues. Beverly Hills (CA): Sage; 1987.
17. Kleinbaum D, Kupper L. Applied regression analysis and other multivariable methods. Duxbury (MA): Duxbury Press; 1978.
18. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27:S178-89.
19. Hawley DJ, Wolfe F. Sensitivity to change of the health assessment questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: results of short-term clinical trials and observational studies versus long-term observational studies. Arthritis Care Res 1992;5:130-6.
20. Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985;28:542-7.
21. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
22. Tugwell P, Bombardier C. A methodologic framework for developing and selecting endpoints in clinical trials. J Rheumatol 1982;9:758-62.
23. Pincus T, Callahan LF, Brooks RH, Fuchs HA, Olsen NJ, Kaye JJ. Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures. Ann Intern Med 1989;110:259-66.
24. Hochberg MC, Sutton JD. Physical disability and psychosocial dysfunction in systemic lupus erythematosus. J Rheumatol 1988;15:959-64.
25. Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, et al. Correlates of the disability index of the Health Assessment Questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum 1999;42:2372-80.